
Rebecca Lehto, PhD, RN, OCN, Assistant Professor, College of Nursing, Michigan State University, discusses symptom burden in lung cancer.
Rebecca Lehto, PhD, RN, OCN, Assistant Professor, College of Nursing, Michigan State University, discusses symptom burden in lung cancer.
Fran Cartwright, PhD, RN-BC, AOCN, Senior Director of Nursing, Oncology Services and Medicine, NYU Langone Medical Center, discusses the importance of understanding the many facets of pain management.
Colleen M. O'Leary, RN, MSN, AOCNS, clinical nurse specialist, head & neck cancers, coordinator, nursing evidence-based practice, The James Cancer Hospital, The Ohio State University, discusses chemotherapy safe handling.
William Strauss, MD, Executive Director, Medical Affairs, AMAG Pharmaceuticals, Inc., discusses a study that analyzed mitigating oral mucositis symptoms in patients with head and neck cancers being treated with chemoradiation therapy.
Jamie S. Myers, PhD, RN, AOCN, adjunct assistant professor, University of Kansas School of Nursing, discusses the importance of having survivorship care plans in place for cancer survivors.
Leslie R. Schover, PhD, clinical psychiatrist, professor, behavioral science, The University of Texas MD Anderson Cancer Center, discusses vaginal dryness and pain in patients with breast cancer treated with aromatase inhibitors.
Charles L. Shapiro, MD, professor, College of Medicine, The James, Ohio State University Comprehensive Care Center, discusses survivorship care.
Ellen T. Matloff, MS, CGC, director, Yale Cancer Genetic Counseling Program at the Yale School of Medicine/Yale Cancer Center, discusses options for BRCA1/2 carriers who are looking to reduce their risk of ovarian cancer.
Leslie R. Schover, PhD, clinical psychiatrist, professor, behavioral science, The University of Texas MD Anderson Cancer Center, discusses the web-based intervention Tendrils: Sexual Renewal and Motherhood after Cancer.
Sharon Lee Parker, director of patient advocacy, John Theurer Cancer Center (JTCC), discusses her job duties and her philosophy on patient hospitality.
Brian Loew, CEO, Inspire, explains how oncology nurses can benefit from online cancer patient communities
Ellen T. Matloff, MS, CGC, director, Yale Cancer Genetic Counseling Program at the Yale School of Medicine/Yale Cancer Center, discusses prophylactic treatment options outside of oophorectomy for BRCA1/2 carriers.
Leslie R. Schover, PhD, clinical psychiatrist, professor, behavioral science, The University of Texas MD Anderson Cancer Center, discusses low sexual desire in breast cancer survivors.
Loretta Muss, coordinator, Patient and Family Advisory Board, co-chair, Partnering with Patients and Families, University of North Carolina Lineberger Comprehensive Cancer Center, North Carolina Cancer Hospital, discusses patient and family centered care.
Matthew Burke, MBA, RN, MSN, APRN-BC, Oncology Nurse Practitioner/Melanoma and Renal Cell Carcinoma, Yale New Haven Hospital, discusses the difference between adverse events caused by chemotherapy and immunotherapy.
Mary Cooley, PhD, APRN, BC, nurse scientist, Phyllis F. Cantor Center for Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute, discusses issues with monitoring symptoms and patient preferences electronically.
Dawn Hershman, MD, MS, medical oncologist, Columbia University Medical Center, discusses the HOPE Study, a randomized trial of exercise vs. usual care on aromatase inhibitor-associated arthralgias in women with breast cancer.
Brian Loew, CEO, Inspire, discusses online cancer patient communities and how they help patients connect and share information.
Colleen M. O'Leary, RN, MSN, AOCNS, clinical nurse specialist, head & neck cancers, coordinator, nursing evidence-based practice, The James Cancer Hospital, The Ohio State University, discusses evidence-based practice in oncology nursing.
Leigh A. Neumayer, MD, professor of surgery, University of Utah School of Medicine, co-director of the multidisciplinary team treating breast cancer at Huntsman Cancer Institute, discusses patient education following a breast cancer diagnosis.
Matthew Burke, MBA, RN, MSN, APRN-BC, Oncology Nurse Practitioner/Melanoma and Renal Cell Carincoma, Yale-New Haven Hospital, discusses the prevalence of immunotherapy-related adverse events.
Donna L. Berry, PhD, RN, AOCN, FAAN, Director, Phyllis F. Cantor Center for Research in Nursing & Patient Care Services, Dana-Farber Cancer Institute, Associate Professor, Department of Medicine, Harvard Medical School, discusses decision support for men with localized prostate cancer.
Charles L. Shapiro, MD, professor, College of Medicine, The James, Ohio State University Comprehensive Care Center, discusses reimbursement for survivorship visits.
Marisa Weiss, MD, founder of Breastcancer.org, discusses women's understanding of breast cancer prevention.
Leigh A. Neumayer, MD, discusses the challenges of recruiting patients for clinical trials.
Nina Grenon, RN, APRN, BC, nurse practitioner, Dana-Farber Cancer Institute, discusses the results of a study that looked at the effect of palliative care in patients with lung cancer.
Sara L. Douglas, PhD, RN, associate professor, Frances Payne Bolton School of Nursing, Case Western Reserve University, discusses the importance of focusing on the caregiver of a patient with cancer.
Martha Polovich, PhD, RN, AOCN, clinical instructor, Byrdine F. Lewis School of Nursing & Health Professions, Georgia State University, discusses the utility of closed system transfer devices (CSTDs).
Sharon Tollin, PhD, ARNP-BC, OCN®, discusses the unmet need for information regarding patients who have undergone prophylactic risk-reducing surgery (such as mastectomy and removal of tubes and ovaries).
Sandra Spoelstra, PhD, RN, assistant professor, Michigan State University, discusses strategies to help improve cancer medication adherence.